Chargement en cours...
Treatment of Alcohol Withdrawal Syndrome with and without Dexmedetomidine
CONTEXT: Studies suggest that dexmedetomidine—an intravenous central-acting α(2)-adrenergic agonist that effectively reduces anxiety among critically ill patients—is being used in patients with severe alcohol withdrawal. However, evidence supporting its use is limited, and it is not approved for thi...
Enregistré dans:
| Publié dans: | Perm J |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
The Permanente Journal
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4867825/ https://ncbi.nlm.nih.gov/pubmed/27168398 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7812/TPP/15-113 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|